Figure 1 — Efficacy and safety analysis of a HER2-targeting antibody-drug conjugate combined with immune checkpoint inhibitors in solid tumors: a real-world study

Navigate

Research Paper|Volume 15, Issue 24|pp. 15473–15488

Efficacy and safety analysis of a HER2-targeting antibody-drug conjugate combined with immune checkpoint inhibitors in solid tumors: a real-world study

Back to articleFigure 1(1 of 4)

100%

Figure 1.Flow diagram of selecting patients.

Figure 1 — Efficacy and safety analysis of a HER2-targeting antibody-drug conjugate combined with immune checkpoint inhibitors in solid tumors: a real-world study | Aging